Dataset | double_gel_and_single_gel_rma_expression_values_collapsed_to_symbols.class.cls #double_gel_8d_versus_single_gel_8d.class.cls #double_gel_8d_versus_single_gel_8d_repos |
Phenotype | class.cls#double_gel_8d_versus_single_gel_8d_repos |
Upregulated in class | double_gel_8d |
GeneSet | RESPONSE_TO_ORGANIC_SUBSTANCE |
Enrichment Score (ES) | 0.62704736 |
Normalized Enrichment Score (NES) | 1.7565377 |
Nominal p-value | 0.0 |
FDR q-value | 0.020385886 |
FWER p-Value | 0.971 |
PROBE | GENE SYMBOL | GENE_TITLE | RANK IN GENE LIST | RANK METRIC SCORE | RUNNING ES | CORE ENRICHMENT | |
---|---|---|---|---|---|---|---|
1 | APOA2 | APOA2 Entrez,  Source | apolipoprotein A-II | 7 | 1.206 | 0.2500 | Yes |
2 | GYS2 | GYS2 Entrez,  Source | glycogen synthase 2 (liver) | 52 | 0.748 | 0.4020 | Yes |
3 | AQP9 | AQP9 Entrez,  Source | aquaporin 9 | 197 | 0.479 | 0.4906 | Yes |
4 | GCK | GCK Entrez,  Source | glucokinase (hexokinase 4, maturity onset diabetes of the young 2) | 259 | 0.427 | 0.5748 | Yes |
5 | ABAT | ABAT Entrez,  Source | 4-aminobutyrate aminotransferase | 450 | 0.320 | 0.6270 | Yes |
6 | CDH13 | CDH13 Entrez,  Source | cadherin 13, H-cadherin (heart) | 1338 | 0.162 | 0.5940 | No |
7 | ME1 | ME1 Entrez,  Source | malic enzyme 1, NADP(+)-dependent, cytosolic | 1535 | 0.147 | 0.6098 | No |
8 | BCL2 | BCL2 Entrez,  Source | B-cell CLL/lymphoma 2 | 2467 | 0.104 | 0.5616 | No |
9 | CHRNA4 | CHRNA4 Entrez,  Source | cholinergic receptor, nicotinic, alpha 4 | 2567 | 0.100 | 0.5750 | No |
10 | GLRX2 | GLRX2 Entrez,  Source | glutaredoxin 2 | 3592 | 0.069 | 0.5124 | No |
11 | EIF2B5 | EIF2B5 Entrez,  Source | eukaryotic translation initiation factor 2B, subunit 5 epsilon, 82kDa | 3870 | 0.063 | 0.5046 | No |
12 | CHRNA7 | CHRNA7 Entrez,  Source | cholinergic receptor, nicotinic, alpha 7 | 4725 | 0.043 | 0.4495 | No |
13 | EIF2B1 | EIF2B1 Entrez,  Source | eukaryotic translation initiation factor 2B, subunit 1 alpha, 26kDa | 5077 | 0.036 | 0.4307 | No |
14 | CHRNB2 | CHRNB2 Entrez,  Source | cholinergic receptor, nicotinic, beta 2 (neuronal) | 6183 | 0.015 | 0.3507 | No |
15 | DUOX2 | DUOX2 Entrez,  Source | dual oxidase 2 | 6346 | 0.011 | 0.3408 | No |
16 | NDUFS4 | NDUFS4 Entrez,  Source | NADH dehydrogenase (ubiquinone) Fe-S protein 4, 18kDa (NADH-coenzyme Q reductase) | 6477 | 0.008 | 0.3327 | No |
17 | GOT2 | GOT2 Entrez,  Source | glutamic-oxaloacetic transaminase 2, mitochondrial (aspartate aminotransferase 2) | 7234 | -0.007 | 0.2774 | No |
18 | RELA | RELA Entrez,  Source | v-rel reticuloendotheliosis viral oncogene homolog A, nuclear factor of kappa light polypeptide gene enhancer in B-cells 3, p65 (avian) | 7310 | -0.008 | 0.2735 | No |
19 | SOD1 | SOD1 Entrez,  Source | superoxide dismutase 1, soluble (amyotrophic lateral sclerosis 1 (adult)) | 7856 | -0.020 | 0.2367 | No |
20 | EIF2B2 | EIF2B2 Entrez,  Source | eukaryotic translation initiation factor 2B, subunit 2 beta, 39kDa | 8183 | -0.027 | 0.2179 | No |
21 | BRCA2 | BRCA2 Entrez,  Source | breast cancer 2, early onset | 10026 | -0.075 | 0.0952 | No |
22 | EIF2B4 | EIF2B4 Entrez,  Source | eukaryotic translation initiation factor 2B, subunit 4 delta, 67kDa | 10082 | -0.077 | 0.1072 | No |
23 | EIF2B3 | EIF2B3 Entrez,  Source | eukaryotic translation initiation factor 2B, subunit 3 gamma, 58kDa | 10112 | -0.079 | 0.1213 | No |
24 | SUPT5H | SUPT5H Entrez,  Source | suppressor of Ty 5 homolog (S. cerevisiae) | 11865 | -0.161 | 0.0233 | No |
25 | ABCG1 | ABCG1 Entrez,  Source | ATP-binding cassette, sub-family G (WHITE), member 1 | 13094 | -0.421 | 0.0186 | No |